Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis

Benchalak Maneeton,1 Suwannee Putthisri,2 Narong Maneeton,1 Pakapan Woottiluk,3 Sirijit Suttajit,1 Chawanun Charnsil,1 Manit Srisurapanont1 1Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, 2Department of Psychiatry, Faculty of Medicine, Ramathibodi Hospital, Mahido...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Maneeton B, Putthisri S, Maneeton N, Woottiluk P, Suttajit S, Charnsil C, Srisurapanont M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2017
Materias:	quetiapine bipolar depression efficacy acceptability Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/790e418100ef4e8a82c04a07dfc0da55
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:790e418100ef4e8a82c04a07dfc0da55
record_format	dspace
spelling	oai:doaj.org-article:790e418100ef4e8a82c04a07dfc0da552021-12-02T07:50:04ZQuetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis1178-2021https://doaj.org/article/790e418100ef4e8a82c04a07dfc0da552017-04-01T00:00:00Zhttps://www.dovepress.com/quetiapine-monotherapy-versus-placebo-in-the-treatment-of-children-and-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Benchalak Maneeton,1 Suwannee Putthisri,2 Narong Maneeton,1 Pakapan Woottiluk,3 Sirijit Suttajit,1 Chawanun Charnsil,1 Manit Srisurapanont1 1Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, 2Department of Psychiatry, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, 3Psychiatric Nursing Division, Faculty of Nursing, Chiang Mai University, Chiang Mai, Thailand Background: Some studies have indicated the efficacy of quetiapine in the treatment of bipolar depression in adult patients. However, its efficacy has been not shown in child and adolescent patients.Objective: This systematic review purposefully determined the efficacy and acceptability of quetiapine in the treatment of children and adolescents with bipolar depression.Data sources: A database search of EMBASE, PubMed, CINAHL, and Cochrane Controlled Trials Register was carried out in March 2016. All randomized controlled trials (RCTs) of bipolar depression in children and adolescents were considered for inclusion in this review.Study eligibility criteria, participants, and interventions: RCTs of quetiapine in the treatment of child and adolescent patients with bipolar depression with end point outcomes were included in this study. Languages were not limited.Study appraisal and synthesis methods: The full-text versions of relevant clinical studies were thoroughly examined and extracted. The primary efficacy of outcome was measured by using the pooled mean-changed scores of the rating scales for bipolar depression. However, the response and remission rates were also measured.Results: A total of 251 randomized patients in the three RCTs of quetiapine versus placebo in the treatment of bipolar depression for children and adolescents were eligible in this review. The pooled mean-changed score of the quetiapine-treated group was not greater than that of the placebo-treated group. Similarly, the pooled response and remission rates were not different between the two groups. The pooled overall discontinuation rate and the discontinuation rate due to adverse events were not different between the two groups.Limitations: Limited studies were eligible in this review.Conclusion: According to the findings in this review, quetiapine may not be efficacious in the treatment of bipolar depression in children and adolescents. Its acceptability, however, was comparable to a placebo. Therefore, the use of quetiapine in children and adolescents with bipolar depression is not recommended. Further well-defined clinical studies should be performed to confirm these outcomes. Keywords: monotherapy, depressive episodes, pharmacological treatment, Children’s Depression Rating Scale–Revised, CDRS-RManeeton BPutthisri SManeeton NWoottiluk PSuttajit SCharnsil CSrisurapanont MDove Medical Pressarticlequetiapinebipolar depressionefficacyacceptabilityNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 13, Pp 1023-1032 (2017)
institution	DOAJ
collection	DOAJ
language	EN
topic	quetiapine bipolar depression efficacy acceptability Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	quetiapine bipolar depression efficacy acceptability Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Maneeton B Putthisri S Maneeton N Woottiluk P Suttajit S Charnsil C Srisurapanont M Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
description	Benchalak Maneeton,1 Suwannee Putthisri,2 Narong Maneeton,1 Pakapan Woottiluk,3 Sirijit Suttajit,1 Chawanun Charnsil,1 Manit Srisurapanont1 1Department of Psychiatry, Faculty of Medicine, Chiang Mai University, Chiang Mai, 2Department of Psychiatry, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, 3Psychiatric Nursing Division, Faculty of Nursing, Chiang Mai University, Chiang Mai, Thailand Background: Some studies have indicated the efficacy of quetiapine in the treatment of bipolar depression in adult patients. However, its efficacy has been not shown in child and adolescent patients.Objective: This systematic review purposefully determined the efficacy and acceptability of quetiapine in the treatment of children and adolescents with bipolar depression.Data sources: A database search of EMBASE, PubMed, CINAHL, and Cochrane Controlled Trials Register was carried out in March 2016. All randomized controlled trials (RCTs) of bipolar depression in children and adolescents were considered for inclusion in this review.Study eligibility criteria, participants, and interventions: RCTs of quetiapine in the treatment of child and adolescent patients with bipolar depression with end point outcomes were included in this study. Languages were not limited.Study appraisal and synthesis methods: The full-text versions of relevant clinical studies were thoroughly examined and extracted. The primary efficacy of outcome was measured by using the pooled mean-changed scores of the rating scales for bipolar depression. However, the response and remission rates were also measured.Results: A total of 251 randomized patients in the three RCTs of quetiapine versus placebo in the treatment of bipolar depression for children and adolescents were eligible in this review. The pooled mean-changed score of the quetiapine-treated group was not greater than that of the placebo-treated group. Similarly, the pooled response and remission rates were not different between the two groups. The pooled overall discontinuation rate and the discontinuation rate due to adverse events were not different between the two groups.Limitations: Limited studies were eligible in this review.Conclusion: According to the findings in this review, quetiapine may not be efficacious in the treatment of bipolar depression in children and adolescents. Its acceptability, however, was comparable to a placebo. Therefore, the use of quetiapine in children and adolescents with bipolar depression is not recommended. Further well-defined clinical studies should be performed to confirm these outcomes. Keywords: monotherapy, depressive episodes, pharmacological treatment, Children’s Depression Rating Scale–Revised, CDRS-R
format	article
author	Maneeton B Putthisri S Maneeton N Woottiluk P Suttajit S Charnsil C Srisurapanont M
author_facet	Maneeton B Putthisri S Maneeton N Woottiluk P Suttajit S Charnsil C Srisurapanont M
author_sort	Maneeton B
title	Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
title_short	Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
title_full	Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
title_fullStr	Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
title_full_unstemmed	Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
title_sort	quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis
publisher	Dove Medical Press
publishDate	2017
url	https://doaj.org/article/790e418100ef4e8a82c04a07dfc0da55
work_keys_str_mv	AT maneetonb quetiapinemonotherapyversusplacebointhetreatmentofchildrenandadolescentswithbipolardepressionasystematicreviewandmetaanalysis AT putthisris quetiapinemonotherapyversusplacebointhetreatmentofchildrenandadolescentswithbipolardepressionasystematicreviewandmetaanalysis AT maneetonn quetiapinemonotherapyversusplacebointhetreatmentofchildrenandadolescentswithbipolardepressionasystematicreviewandmetaanalysis AT woottilukp quetiapinemonotherapyversusplacebointhetreatmentofchildrenandadolescentswithbipolardepressionasystematicreviewandmetaanalysis AT suttajits quetiapinemonotherapyversusplacebointhetreatmentofchildrenandadolescentswithbipolardepressionasystematicreviewandmetaanalysis AT charnsilc quetiapinemonotherapyversusplacebointhetreatmentofchildrenandadolescentswithbipolardepressionasystematicreviewandmetaanalysis AT srisurapanontm quetiapinemonotherapyversusplacebointhetreatmentofchildrenandadolescentswithbipolardepressionasystematicreviewandmetaanalysis
_version_	1718399164723757056

Quetiapine monotherapy versus placebo in the treatment of children and adolescents with bipolar depression: a systematic review and meta-analysis

Ejemplares similares